TA  - TO BE PUBLISHED
OWN - RCSB PDB
TI  - Novel pyrrolo[2,3-f]isoquinoline based MAPKAP-K2 (MK2) inhibitors with potent in vitro and in vivo activity
FAU - Revesz, L., Schlapbach, A., Aichholz, R., Feifel, R., Hawtin, S., Heng, R., Hiestand, P., Jahnke, W., Koch, G., Moebitz, H., Scheufler, C., Velcicky, J., Huppertz, C.
CRDT - 2010/03/10 12:00
AID - 10.2210/pdb3m42/pdb [doi]
SO  - http://www.rcsb.org/structure/3M42